Cargando…
Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?
The current World Health Organization guidance is not to start corticosteroids, but there is no robust evidence of risk in patients with cancer and coronavirus disease 2019. A risk-benefit analysis should be performed for each patient on the use of steroids in cancer care.
Autores principales: | Waterhouse, Jasmin V., Hull, James H., Linch, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association of Urology. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172651/ https://www.ncbi.nlm.nih.gov/pubmed/32349935 http://dx.doi.org/10.1016/j.eururo.2020.04.027 |
Ejemplares similares
-
Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid
por: Takumida, Hiroshi, et al.
Publicado: (2021) -
Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis
por: Zeng, Yiqian, et al.
Publicado: (2022) -
Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis
por: Zeng, Yiqian, et al.
Publicado: (2022) -
Treating Gastrointestinal Cancer During the Coronavirus Disease 2019 Pandemic in Europe
por: Collienne, Maike, et al.
Publicado: (2020) -
Asthma, biologics, corticosteroids, and coronavirus disease 2019
por: Akenroye, Ayobami T., et al.
Publicado: (2020)